Sara Hurvitz, MD | Authors

Articles

Pembrolizumab for TNBC

December 11, 2014

Sara Hurvitz, MD, medical oncologist, UCLA Medical Center, discusses the results of a study looking at pembrolizumab (Keytruda) in patients with triple-negative breast cancer (TNBC).